Cancer cells often hijack normal signaling pathways to promote their survival and proliferation. Key pathways include the PI3K/AKT pathway, the MAPK pathway, and the Wnt signaling pathway. Dysregulation of these pathways can lead to uncontrolled cell division and resistance to apoptosis. Targeting these pathways with specific inhibitors is a promising avenue for cancer treatment.
